Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Peter Lio MD, FAAD

Peter A. Lio MD, FAAD

Clinical Assistant Professor of Dermatology and Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois; Founding Partner, Medical Dermatology Associates of Chicago, Chicago, Illinois; Founding Director, Chicago Integrative Eczema Center, Chicago, Illinois

Peter Lio, MD, is a Clinical Assistant Professor of Dermatology & Pediatrics at Northwestern University Feinberg School of Medicine. Dr. Lio received his medical degree from Harvard Medical School, completed his internship in Pediatrics at Boston Children’s Hospital, and his Dermatology training at Harvard where he served as Chief Resident in Dermatology. While at Harvard, he received formal training in acupuncture. Dr. Lio is the founding director of the Chicago Integrative Eczema Center and a founding partner of Medical Dermatology Associates of Chicago. He currently serves as a board member and scientific advisory committee member for the National Eczema Association. He is a member of the American Academy of Dermatology’s Atopic Dermatitis Expert Resource Group and a founding faculty member of the Integrative Dermatology Certificate Program. He has over 150 publications and 2 textbooks.

Disclosures

Dr. Lio reports research grants/funding from Regeneron/Sanofi Genzyme, and Abbvie; is on the speaker's bureau for Regeneron/Sanofi Genzyme, Pfizer, and Galderma; reports consulting/advisory boards for UCB, Dermavant, Regeneron/Sanofi Genzyme, Dermira, Pfizer, LEO Pharmaceuticals, Abbvie, Kiniksa, Eli Lilly, Menlo Therapeutics, Galderma, IntraDerm, Exeltis, Realm Therapeutics.

Recent Contributions to PracticeUpdate:

  1. Antibiotic Use Within the First Year of Life Is Associated With Infant Gut Microbiome Disruption and Elevated Atopic Dermatitis Risk
  2. Clinical Efficacy of Probiotics in the Treatment of Patients With Acne Vulgaris
  3. Safety and Effectiveness of Oral Nutraceuticals for Treating Patients With Acne
  4. Efficacy of Integrated Online Mindfulness and Self-Compassion Training for Adults With Atopic Dermatitis
  5. Effect of Vitamin D Supplementation on Psoriasis Severity in Patients With Lower-Range Serum 25-Hydroxyvitamin D Levels
  6. Effects of Probiotics Supplementation on Skin Photoaging and Skin Barrier Function
  7. Benefits and Harms of Allergen Immunotherapy for Atopic Dermatitis
  8. Awareness of Dupilumab-Induced Facial Redness
  9. Influence of Exercise on Skin Aging, Skin Health, and Androgenetic Alopecia
  10. Effects of Hydrolyzed Collagen Supplementation on Skin Aging

Most Read This Week

Recently Updated